Skip directly to search
Skip directly to A to Z list
Skip directly to navigation
Skip directly to page options
Skip directly to site content
Start of Search Controls
Search Form Controls
Search The CDC
submit
CDC A-Z Index
MENU
CDC A-Z
SEARCH
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
#
Search Form Controls
Search The CDC
submit
CDC A-Z Index
Public Health Genomics and Precision Health Knowledge Base (v9.0)
PHGKB
About
Public Health Genomics Branch
PHGKB Weekly Horizon Scan
Genomics Precision Health Scan
Advanced Molecular Detection Clips
Non-Genomics Precision Health Scan
CDC-authored Publications Scan
Specialized PHGKB
Cancer PHGKB
Diabetes PHGKB
Economic Evaluation PHGKB
Environmental Health PHGKB
Family Health History PHGKB
Health Equity PHGKB
HLBS-PopOmics
Infectious Diseases PHGKB
Implementation Science PHGKB
Neurological Disorders PHGKB
Pharmacogenomics PHGKB
Primary Immune Deficiency Diseases PHGKB
Rare Diseases PHGKB
Reproductive and Child Health PHGKB
All Databases
COVID-19 GPH (47318)
CDC/NIH Web Information Database (32178)
CDC-Authored Genomics and Precision Health Publications Database (5836)
Precision Health Database (63653)
Tier-Classified Guidelines Database (533)
Pathogen Advanced Molecular Detection Database (26729)
All of Us Reports and Publications Database (672)
Human Genome Epidemiology
Human Genome Epidemiology Literature Finder (226390)
Epigenetic Epidemiology Publications Database (22739)
Release Note
Contact Us
Human Genome Epidemiology Literature Finder|Home|PHGKB
Human Genome Epidemiology Literature Finder
Last data update: Apr 23, 2024
. (Total: 226390Documents)
All
Cancer
Diabetes
Economic
Environmental
Equity
FHH
HLBS
ID
Implementation
ND
PGx
PI
Rare
RCH
dataset
GWAS Only
Filtered By
:
Select to fine-tune your search
Disease
Gene
Year
Journal
Country
Study Design
Previous
Records 1 - 17 (of 17 Records)
Query Trace:
Diarrhea and meta-analysis and EGFR[original query]
Combination of EGFR-TKIs and chemotherapy as first-line therapy for advanced NSCLC: a meta-analysis.
PloS one 2013 8 (11): e79000.
OuYang Pu-Yun, Su Zhen, Mao Yan-Ping, Deng Wuguo, Xie Fang-Y
Similar articles in PubMed
Network meta-analysis of erlotinib, gefitinib, afatinib and icotinib in patients with advanced non-small-cell lung cancer harboring EGFR mutations.
PloS one 2014 9 (2): e85245.
Liang Wenhua, Wu Xuan, Fang Wenfeng, Zhao Yuanyuan, Yang Yunpeng, Hu Zhihuang, Xue Cong, Zhang Jing, Zhang Jianwei, Ma Yuxiang, Zhou Ting, Yan Yue, Hou Xue, Qin Tao, Dinglin Xiaoxiao, Tian Ying, Huang Peiyu, Huang Yan, Zhao Hongyun, Zhang
Similar articles in PubMed
Risk of Treatment-Related Toxicities from EGFR Tyrosine Kinase Inhibitors: A Meta-analysis of Clinical Trials of Gefitinib, Erlotinib, and Afatinib in Advanced EGFR-Mutated Non-Small Cell Lung Cancer.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2016 Dec .
Ding Pei Ni, Lord Sarah J, Gebski Val, Links Matthew, Bray Victoria, Gralla Richard J, Yang James Chih-Hsin, Lee Chee Kho
Similar articles in PubMed
Efficacy of epidermal growth factor receptor inhibitors in combination with chemotherapy in advanced non-small cell lung cancer: a meta-analysis of randomized controlled trials.
Oncotarget 2016 May .
Zhang Minghui, Guo Hongsheng, Zhao Shu, Wang Yan, Yang Maopeng, Yu Jiawei, Yan Yubo, Wang Y
Similar articles in PubMed
The efficacy and toxicity of afatinib in advanced EGFR-positive non-small-cell lung cancer patients after failure of first-generation tyrosine kinase inhibitors: a systematic review and meta-analysis.
Journal of thoracic disease 2017 8 9 (7): 1980-1987.
Zhang Yaxiong, Miao Siyu, Wang Fang, Fang Wenfeng, Chen Gang, Chen Xi, Yan Fang, Huang Xiaodan, Wu Manli, Huang Yan, Zhang
Similar articles in PubMed
Comparison of gefitinib, erlotinib and afatinib in non-small cell lung cancer: A meta-analysis.
International journal of cancer 2017 06 140 (12): 2805-2819.
Yang Zuyao, Hackshaw Allan, Feng Qi, Fu Xiaohong, Zhang Yuelun, Mao Chen, Tang Jinli
Similar articles in PubMed
The Impact of Afatinib on Survival in Advanced Non-Small Cell Lung Cancer: A Meta-Analysis of Randomized Controlled Trials.
Journal of Cancer 2019 3 10 (4): 885-892.
Wang Chi, Li Yun, Ke Li, Cao Lejie, Fan Pingsheng, Wu Zhiwei, Wu Qu
Similar articles in PubMed
Diarrhea with epidermal growth factor receptor tyrosine kinase inhibitors in cancer patients: A meta-analysis of randomized controlled trials.
Critical reviews in oncology/hematology 2019 2 134 31-38.
Li Jing, Gu Ji
Similar articles in PubMed
Eye, hepatobiliary, and renal disorders of erlotinib in patients with non-small-cell lung cancer: A meta-analysis.
PloS one 2020 7 15 (7): e0234818.
Choi Hye Duck, Chang Min Ju
Similar articles in PubMed
Efficacy and safety of erlotinib combined with bevacizumab in the treatment of non-small cell lung cancer: A systematic review and meta-analysis.
Medicine 2020 Jan 99 (3): e18771.
Zhou Kenan, Zhao Shishun, Guo Wenlai, Ding L
Similar articles in PubMed
Pemetrexed/carboplatin plus gefitinib as a first-line treatment for EGFR-mutant advanced nonsmall cell lung cancer: a Bayesian network meta-analysis.
Therapeutic advances in medical oncology 2019 11 1758835919891652.
Zhang Zhonghan, Zeng Kangmei, Zhao Shen, Zhao Yuanyuan, Hou Xue, Luo Fan, Lu Feiteng, Zhang Yaxiong, Zhou Ting, Ma Yuxiang, Yang Yunpeng, Fang Wenfeng, Huang Yan, Zhang Li, Zhao Hongy
Similar articles in PubMed
Current Evidence of the Efficacy and Safety of Neoadjuvant EGFR-TKIs for Patients With Non-small Cell Lung Cancer.
Frontiers in oncology 2021 11 608608.
Shi Xiaoshun, Dong Xiaoying, Zhai Jianxue, Liu Xiguang, Lu Di, Ni Zhen, Wu Hua, Cai Kaic
Similar articles in PubMed
Efficacy and safety of anti-angiogenic drugs combined with erlotinib in the treatment of advanced non-small cell lung cancer: a meta-analysis of randomized clinical trials.
Annals of palliative medicine 2021 2 10 (3): 2687-2698.
Chen Zheng, Jiang Shu, Li Xuechun, Zhang Jingyao, Liu Liu, Li Juan, Cao Peiyu, Xin Yong, Zhang Longzh
Similar articles in PubMed
Efficacy and Safety of Afatinib in the Treatment of Advanced Non-Small-Cell Lung Cancer with EGFR Mutations: A Meta-Analysis of Real-World Evidence.
Journal of oncology 2021 12 2021 8736288.
Zhang Lemeng, Luo Yongzhong, Chen Jianhua, Cheng Tianli, Yang Hua, Pan Changqie, Li Haitao, Jiang Zh
Similar articles in PubMed
Efficacy and safety of adjuvant EGFR-TKIs for resected non-small cell lung cancer: a systematic review and meta-analysis based on randomized control trials.
BMC cancer 2022 3 22 (1): 328.
Zhao Pengfei, Zhen Hongchao, Zhao Hong, Zhao Lei, Cao Bangw
Similar articles in PubMed
Efficacy and safety of osimertinib for patients with EGFR-mutated NSCLC: a systematic review and meta-analysis of randomized controlled studies.
Acta oncologica (Stockholm, Sweden) 2022 10 61 (11): 1347-1353.
Li Li, Huang Qin, Sun Jianhai, Yan Fei, Wei Wujie, Li Zihui, Liu Li, Deng J
Similar articles in PubMed
Side effects of tyrosine kinase inhibitors therapy in patients with non-small cell lung cancer and associations with EGFR polymorphisms: A systematic review and meta-analysis.
Oncology letters 2023 1 25 (2): 62.
Obradovic Jasmina, Todosijevic Jovana, Jurisic Vladim
Similar articles in PubMed
File Formats Help:
How do I view different file formats (PDF, DOC, PPT, MPEG) on this site?
Adobe PDF file
Microsoft PowerPoint file
Microsoft Word file
Microsoft Excel file
Audio/Video file
Apple Quicktime file
RealPlayer file
Text file
Zip Archive file
SAS file
ePub file
Page last reviewed:
Feb 1, 2024
Page last updated:
Apr 22, 2024
Content source:
Public Health Genomics Branch in the Division of Blood Disorders and Public Health Genomics
,
National Center on Birth Defects and Developmental Disabilities
TOP